Infinity Pharmaceuticals Inc (INFI)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

784 MEMORIAL DRIVE CAMBRIDGE, MA 02139

Provides products and services designed to make the drug discovery process faster, less expensive and more likely to generate a quality drug candidate. Offers products and services in many functional disciplines of the drug discovery process that can be purchased solo or as integrated solutions.

Data based on most recent fiscal year report
Market Cap99.392 Million Shares Outstanding50.71 Million Avg Volume1.927 Million
1-Yr BETA vs S&P TR1.251 Current Ratio5.03 Quick Ratio5.03
View SEC Filings from INFI instead.
Q1 2019 All Institutions Hedge Funds 1
To trade INFI now:
Filers who had this stock in their top 10: 1 1 (0.1%)
13F Filers holding this stock: 64 10 (1.02%)
Aggregate 13F shares on 03/31/2019: 30.926 Million 20.69 Million
Aggregate 13F shares on 12/31/2018: 30.774 Million 21.069 Million
Percent change: 0.50% -1.80%
Funds creating new positions: 9 2
Funds Adding to an existing position: 14 2
Funds closing out their position: 10 3
Funds reducing their position: 17 3
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding INFI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PERKINS ADELENE Q CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-06-13 3

SELBY NORMAN C

  • Director
0 2019-06-13 1

EVNIN ANTHONY B

  • Director
143,138 2019-06-13 1

VENUTI MICHAEL C

  • Director
0 2019-06-13 1

BLOCH LAWRENCE E PRESIDENT

  • Officer
0 2019-06-13 2

BERKOWITZ JEFFREY

  • Director
85,238 2019-06-13 1

BERTRAND WILLIAM C JR

  • Director
52,135 2019-06-13 0

KAUFFMAN MICHAEL

  • Director
0 2019-06-13 1

BEIER DAVID W

  • Director
0 2019-06-13 1

SATO VICKI L

  • Director
0 2019-06-11 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
169,589 2019-06-10 5

LYNCH THOMAS J. JR. EVP & CHIEF SCIENTIFIC OFFICER

  • Officer
22,223 2019-04-03 0

PALOMBELLA VITO J. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-03-01 0

BABLER MARTIN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-03-01 0

QUIRK GERALD E CHIEF LEGAL & ADMIN. OFFICER

  • Officer
87,000 2019-02-12 0

ROTH DAVID CHIEF MEDICAL OFFICER

  • Officer
87,000 2019-02-12 0

KANGO SUJAY SVP, CHIEF COMMERCIAL OFFICER

  • Officer
10,050 2019-01-25 0

TASKER SETH A GENERAL COUNSEL

  • Officer
0 2019-01-04 1

KUTOK JEFFERY CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-01-04 3

AGRESTA SAMUEL CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-04 3

FYFE GWEN A.

15,000 2018-10-25 0

BASELGA JOSE

  • Director
No longer subject to file 2018-09-30 0

SMITH IAN F EVP, COO

  • Officer
52,005 2018-06-29 0

ADAMS JULIAN

  • Director
0 2018-06-26 0

LANDER ERIC S

  • Director
134,000 2018-06-26 0

LEVINE ARNOLD J

  • Director
0 2018-06-08 0

HIXSON HARRY F JR

  • Director
0 2016-06-13 0

LINDBLOM CHRISTOPHER M PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2016-05-02 0

HOLTZMAN STEVEN H EVP CORPORATE DEVELOPMENT

  • Officer
No longer subject to file 2016-02-23 0

LAM WINSTON K.C. GENERAL COUNSEL

  • Officer
0 2015-04-15 0

SANTABARBARA PEDRO CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2014-01-10 0

ROSEBAY MEDICAL CO L.P.

  • 10% Owner
No longer subject to file 2013-04-16 0

BEACON CO

  • 10% Owner
No longer subject to file 2013-04-16 0

HAMERMESH JOSHUA VP, BUSINESS & CORPORATE DEV

  • Officer
0 2013-01-04 0

TUCKER WINSELOW S. JR. VICE PRESIDENT, MARKETING

  • Officer
0 2013-01-04 0

LEE PATRICK PAK-TIN

  • Director
0 2012-05-16 0

TANANBAUM JAMES B

  • Director
0 2011-05-18 0

MOSS FRANKLIN

  • Director
0 2010-05-25 0

TONG JEFFREY K VP, COR. & PRODUCT DEVELOPMENT

  • Officer
0 2010-01-05 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BERKOWITZ JEFFREY - Director

2019-06-13 A 26,250 $1.60 a 85,238 85,238.00 direct

SELBY NORMAN C - Director

2019-06-13 A 10,000 a 0 0.00 direct

VENUTI MICHAEL C - Director

2019-06-13 A 30,000 a 30,000 0.00 direct

PERKINS ADELENE Q - Director - Officer CHIEF EXECUTIVE OFFICER

2019-06-13 A 242,000 a 242,000 0.00 direct

EVNIN ANTHONY B - Director

2019-06-13 A 30,000 a 30,000 143,138.00 direct

SELBY NORMAN C - Director

2019-06-13 A 30,000 a 0 0.00 direct

BLOCH LAWRENCE E - Officer PRESIDENT

2019-06-13 A 100,000 a 100,000 0.00 direct

BERKOWITZ JEFFREY - Director

2019-06-13 A 30,000 a 30,000 85,238.00 direct

EVNIN ANTHONY B - Director

2019-06-13 A 13,125 $1.60 a 143,138 143,138.00 direct

BEIER DAVID W - Director

2019-06-13 A 30,000 a 30,000 0.00 direct

KAUFFMAN MICHAEL - Director

2019-06-13 A 30,000 a 30,000 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments